Back
Arbutus Biopharma Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
ABUS
Arbutus Biopharma
Last Price:
3.50
Seasonality Move:
15.21%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
Arbutus Biopharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.59 | Sell |
| 20-day SMA: | 3.79 | Sell |
| 50-day SMA: | 3.93 | Sell |
| 200-day SMA: | 3.37 | Buy |
| 8-day EMA: | 3.59 | Sell |
| 20-day EMA: | 3.73 | Sell |
| 50-day EMA: | 3.83 | Sell |
| 200-day EMA: | 3.43 | Buy |
Arbutus Biopharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 28.99 | Sell |
| Chaikin Money Flow: | -417405 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.64 - 4.06) | Sell |
| Bollinger Bands (100): | (3.55 - 4.13) | Sell |
Arbutus Biopharma Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arbutus Biopharma Stock
Is Arbutus Biopharma Stock a Buy?
- Arbutus Biopharma share price is 3.44 while ABUS 8-day simple moving average is 3.59, which is a Sell signal.
- The stock price of ABUS is 3.44 while Arbutus Biopharma 20-day SMA is 3.79, which makes it a Sell.
- Arbutus Biopharma 50-day simple moving average is 3.93 while ABUS share price is 3.44, making it a Sell technically.
- ABUS stock price is 3.44 and Arbutus Biopharma 200-day simple moving average is 3.37, creating a Buy signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
36
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy or a Sell?
-
Arbutus Biopharma stock is rated a Sell
The current Arbutus Biopharma [ABUS] share price is $3.44. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Stock Info
Market Cap:
651.85M
Price in USD:
3.44
Share Volume:
626.37K
Arbutus Biopharma 52-Week Range
52-Week High:
4.73
52-Week Low:
1.79
Sell
36
Arbutus Biopharma (ABUS)
is a Sell
Arbutus Biopharma Share Price Forecast
-
What is the Arbutus Biopharma stock price today?
The Arbutus Biopharma stock price is 3.44 USD today. -
Will ABUS stock go up or go down?
Arbutus Biopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Arbutus Biopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma is overvalued.
Is Arbutus Biopharma Stock a Buy?
- Arbutus Biopharma share price is 3.44 while ABUS 8-day exponential moving average is 3.59, which is a Sell signal.
- The stock price of ABUS is 3.44 while Arbutus Biopharma 20-day EMA is 3.73, which makes it a Sell.
- Arbutus Biopharma 50-day exponential moving average is 3.83 while ABUS share price is 3.44, making it a Sell technically.
- ABUS stock price is 3.44 and Arbutus Biopharma 200-day simple moving average is 3.43, creating a Buy signal.
Fundamental Analysis of Arbutus Biopharma
Is Arbutus Biopharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Technical Analysis of Arbutus Biopharma
Should I short Arbutus Biopharma stock?
- ABUS Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Arbutus Biopharma is a Sell
- Arbutus Biopharma Relative Strength Index (RSI) is 28.99, which suggest Arbutus Biopharma is oversold
- The Bollinger Bands (25) for Arbutus Biopharma is (3.64 - 4.06), which suggest Arbutus Biopharma is a Sell
- The Bollinger Bands (100) for Arbutus Biopharma is (3.55 - 4.13), which suggest Arbutus Biopharma is a Sell
* Arbutus Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.